Business Context and Reporting Period
This Form 6-K filing by iHuman Inc. (NYSE: IH) covers the month of September 2021, with the report dated September 29, 2021. The company is a foreign private issuer headquartered in Beijing, China.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is a modification to the composition of the Audit Committee effective October 1, 2021:
- Departure: Ms. Vivien Weiwei Wang no longer serves on the Audit Committee to ensure full independence.
- Continued Role: Ms. Wang remains a director and the Chief Financial Officer of the Company.
- New Composition: The committee now consists of two independent directors: Ms. Wendy Hayes and Ms. Xuenan Li.
- Regulatory Status: The Company relies on home country practice to be exempted from the NYSE Listed Company Manual requirement that the audit committee must have a minimum of three members.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the disclosure of the audit committee change.
Investor Verification Checklist
- Verify the current composition of the Audit Committee on the company's investor relations page.
- Confirm the Company's reliance on home country practice regarding the minimum number of audit committee members under NYSE rules.
- Review subsequent filings for any financial data, as this 6-K contains no financial metrics.